跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
antibacterial agents
首页
药物
antibacterial agents
antibacterial agents
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Antibacterial agents
US 7358359 B2
申请人: UNIV WASHINGTON
优先权: 2003
CN
US
14 件公开
US 8088791 B2
申请人: BROWN DAVID RYALL
优先权: 2006
EP
US
WO
9 件公开
US 7148198 B2
申请人: BRITISH BIOTECH PHARM
优先权: 1998
US
7 件公开
US 7053234 B2
申请人: AMGEN INC
优先权: 2001
US
6 件公开
EP 4259602 A4
申请人: UNIV PRINCETON
优先权: 2020
EP
US
WO
4 件公开
US 7186719 B2
申请人: BRITISH BIOTECH PHARM
优先权: 1999
US
4 件公开
US 7511035 B2
申请人: GLAXO GROUP LTD
优先权: 2006
US
4 件公开
US 7989422 B2
申请人: ALCHEMIA LTD
优先权: 2005
EP
US
3 件公开
US 2010190766 A1
申请人: ACHAOGEN INC
优先权: 2007
CN
US
3 件公开
US 2007191394 A1
申请人: WARNER LAMBERT CO
优先权: 2004
US
3 件公开
US 2003114458 A1
申请人: ELLSWORTH EDMUND LEE
优先权: 2002
US
2 件公开
US 7067620 B2
申请人: THERAVANCE INC
优先权: 2002
US
2 件公开
US 7192953 B2
申请人: VERNALIS OXFORD LTD
优先权: 2002
US
2 件公开
US 7217726 B2
申请人: ORCHID CHEMICALS & PHARM LTD
优先权: 2003
US
2 件公开
US 7304050 B2
申请人: PFIZER
优先权: 2004
US
2 件公开
US 7232832 B2
申请人: SMITHKLINE BEECHAM CORP
优先权: 2005
US
2 件公开
US 7618959 B2
申请人: GLAXO GROUP LTD
优先权: 2005
US
2 件公开
US 7691850 B2
申请人: GLAXO GROUP LTD
优先权: 2005
US
2 件公开
US 7648984 B2
申请人: GLAXO GROUP LTD
优先权: 2005
US
2 件公开
US 7524860 B2
申请人: WARNER LAMBERT CO
优先权: 2005
US
2 件公开
US 2008234256 A1
申请人: GLAXO GROUP LTD
优先权: 2006
US
2 件公开
US 7592334 B2
申请人: GLAXO GROUP LTD
优先权: 2006
US
2 件公开
US 7605169 B2
申请人: GLAXO GROUP LTD
优先权: 2006
US
2 件公开
US 7648980 B2
申请人: GLAXO GROUP LTD
优先权: 2006
US
2 件公开
US 7989430 B2
申请人: UNIV MINNESOTA
优先权: 2006
US
2 件公开
US 7655648 B2
申请人: GLAXO GROUP LTD
优先权: 2007
US
2 件公开
US 7700590 B2
申请人: UNIV NEW ORLEANS RES AND TECHN
优先权: 2007
US
2 件公开
US 7709496 B2
申请人: GLAXO GROUP LTD
优先权: 2007
US
2 件公开
US 8492414 B2
申请人: HAYDON DAVID JOHN
优先权: 2007
US
2 件公开
US 6369050 B1
申请人: FUJISAWA PHARMACEUTICAL CO
优先权: 1998
US
US 6503897 B1
申请人: BRITISH BIOTECH PHARM
优先权: 1999
US
CN 101007784 A
申请人: BRITISH BIOTECH PHARM
优先权: 1999
CN
US 6908911 B1
申请人: BRITISH BIOTECH PHARM
优先权: 1999
US
US 2003180319 A1
申请人: RAPSON MARK EDWARD
优先权: 2002
US
US 2006089363 A1
申请人: VERNALIS OXFORD LTD
优先权: 2002
US
US 2003114666 A1
申请人: ELLSWORTH EDMUND LEE
优先权: 2002
US
US 2007129310 A1
申请人: VERNALIS OXFORD LTD
优先权: 2002
US
US 2006172990 A1
申请人: EAST STEPHEN P
优先权: 2002
US
US 2005113450 A1
申请人: THORARENSEN ATLI
优先权: 2003
US
US 2004224939 A1
申请人: CHUPAK LOUIS S
优先权: 2004
US
US 2005277630 A1
申请人: CHUPAK LOUIS S
优先权: 2004
US
US 2005288273 A1
申请人: BOYER FREDERICK E JR
优先权: 2004
US
US 2008207536 A1
申请人: RANBAXY LAB LTD
优先权: 2004
US
US 2005096278 A1
申请人: ELLSWORTH EDMUND L
优先权: 2004
US
US 2005096297 A1
申请人: ELLSWORTH EDMUND L
优先权: 2004
US
US 2005096308 A1
申请人: ELLSWORTH EDMUND L
优先权: 2004
US
US 2008318878 A1
申请人: DAS BISWAJIT
优先权: 2004
US
US 2007191333 A1
申请人: WARNER LAMBERT CO
优先权: 2004
US
US 2005203102 A1
申请人: ORCHID CHEMICALS & PHARM LTD
优先权: 2005
US
US 2006041123 A1
申请人: AXTEN JEFFREY M
优先权: 2005
US
US 2008194547 A1
申请人: GLAXO GROUP LTD
优先权: 2005
US
US 2007254872 A1
申请人: GLAXO GROUP LTD
优先权: 2005
US
US 2007270417 A1
申请人: GLAXO GROUP LTD
优先权: 2005
US
US 2007161627 A1
申请人: MILLER WILLIAM H
优先权: 2005
US
US 2006189601 A1
申请人: HENNESSY ALAN J
优先权: 2005
US
US 2009221655 A1
申请人: PITZER INC
优先权: 2007
US
CN 101404989 B
申请人: PROLYSIS LTD
优先权: 2007
CN
US 2008262083 A1
申请人: IDEXX LAB INC
优先权: 2008
US
US 10947271 B2
申请人: UNIV QUEENSLAND
优先权: 2014
US
US 2015175530 A1
申请人: ACHAOGEN INC
优先权: 2014
US
US 9403758 B2
申请人: ACHAOGEN INC
优先权: 2014
US
CN 119698426 A
申请人: ISIS INNOVATION
优先权: 2022
CN
NOVEL ANTIBACTERIAL AGENTS
EP 3738591 A3
申请人: MERCK SHARP & DOHME
优先权: 2003
EP
US
9 件公开
US 2007154948 A1
申请人: CHRISTENSEN BURTON G
优先权: 2006
US
3 件公开
US 2007134729 A1
申请人: CHRISTENSEN BURTON G
优先权: 2006
US
US 2007167414 A1
申请人: ORCHID CHEMICALS & PHARM LTD
优先权: 2007
US
CEACAM based antibacterial agents
US 8298544 B2
申请人: MARKEL GAL
优先权: 2007
US
9 件公开
Tricyclic tetrahydroquinoline antibacterial agents
US 7208490 B2
申请人: PHARMACIA & UPJOHN CO LLC
优先权: 2003
US
7 件公开
US 8952149 B2
申请人: CURTIS MICHAEL
优先权: 2013
CN
US
4 件公开
Cyanopyridine antibacterial agents
US 7737164 B2
申请人: WISCONSIN ALUMNI RES FOUND
优先权: 2007
US
6 件公开
Lipopeptides as antibacterial agents
US 6911525 B2
申请人: CUBIST PHARM INC
优先权: 2000
EP
US
5 件公开
US 7408025 B2
申请人: CUBIST PHARM INC
优先权: 2000
US
4 件公开
US 6794490 B2
申请人: CUBIST PHARM INC
优先权: 2000
US
2 件公开
8-pyrazinyl-S-spiropyrimidinetrione-oxazinoquinoline derivatives as antibacterial agents
EP 2620439 A1
申请人: PAH USA 15 LLC
优先权: 2005
EP
US
4 件公开
Screening process for antibacterial agents
US 7892782 B2
申请人: HELPERBY THERAPEUTICS LTD
优先权: 2001
US
4 件公开
ANTIBACTERIAL AGENTS & METHODS
EP 3969021 A1
申请人: FOLIUM FOOD SCIENCE LTD
优先权: 2019
EP
US
WO
3 件公开
Phenicol antibacterial agents
CN 104684898 A
申请人: ZOETIS LLC
优先权: 2013
CN
US
3 件公开
US 9422236 B2
申请人: ZOETIS SERVICES LLC
优先权: 2014
US
第 1 / 3 页
上一页
下一页
药物
反馈